Jonathan Couchman, 10% Owner at ENZON PHARMACEUTICALS, INC. (ENZN), bought 1,529,735 shares at $0.26 ($379K) on 2018-08-15, disclosed to the SEC on 2019-01-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.26 | 20,600 | $5K | 1.4% |
| 2 | $0.26 | 20,600 | $5K | 1.4% |
| 3 | $0.26 | 8,800 | $2K | 0.6% |
| 4 | $0.26 | 8,800 | $2K | 0.6% |
| 5 | $0.26 | 67,200 | $17K | 4.6% |
| 6 | $0.21 | 100,000 |
| $21K |
| 5.5% |
| 7 | $0.21 | 100,000 | $21K | 5.5% |
| 8 | $0.21 | 2,500 | $525 | 0.1% |
| 9 | $0.22 | 15,000 | $3K | 0.9% |
| 10 | $0.22 | 15,000 | $3K | 0.9% |
| 11 | $0.22 | 40,050 | $9K | 2.3% |
| 12 | $0.22 | 42,450 | $9K | 2.5% |
| 13 | $0.22 | 450 | $99 | 0.0% |
| 14 | $0.22 | 1,100 | $242 | 0.1% |
| 15 | $0.22 | 2,500 | $550 | 0.1% |
| 16 | $0.23 | 15,261 | $4K | 0.9% |
| 17 | $0.24 | 213,189 | $50K | 13.3% |
| 18 | $0.24 | 213,189 | $51K | 13.5% |
| 19 | $0.27 | 312,523 | $84K | 22.2% |
| 20 | $0.27 | 312,523 | $84K | 22.3% |
| 21 | $0.26 | 4,500 | $1K | 0.3% |
| 22 | $0.26 | 4,500 | $1K | 0.3% |
| 23 | $0.26 | 2,500 | $638 | 0.2% |
| 24 | $0.26 | 2,500 | $650 | 0.2% |
| 25 | $0.26 | 2,000 | $510 | 0.1% |
| 26 | $0.26 | 2,000 | $520 | 0.1% |
| Total | $0.25 avg | 1,529,735 | $379K | 100% |
| Filing → |
| ENZN | BUY | 2019-01-09 | $259K | — | Filing → |